Jacobs Levy Equity Management, Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $166,646 - $238,641	-2,601 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $5.27 Million - $7.95 Million	-80,964 Reduced 96.89%	2,601 $223,000
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $1.61 Million - $2.12 Million	27,230 Added 48.34%	83,565 $5.43 Million
Q2 2020 Aug 17, 2020	SELL	$29.01 - $74.23 $68,637 - $175,628	-2,366 Reduced 4.03%	56,335 $4.12 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $1.61 Million - $3.36 Million	58,701 New	58,701 $2 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.